Bob D. Brown

Insider Reports History

Entity
Individual
Location
C/O Dicerna Pharmaceuticals, Inc., 75 Hayden Avenue, Lexington, Massachusetts
Signature
/s/ Douglas W. Pagan, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Bob D. Brown:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Dicerna Pharmaceuticals Inc Chief Scientific Ofr., EVP R&D Common Stock 0 $38.25 Dec 28, 2021 Direct
Dicerna Pharmaceuticals Inc Chief Scientific Ofr., EVP R&D Restricted Stock Units 0 Dec 28, 2021 Direct
Dicerna Pharmaceuticals Inc Chief Scientific Ofr., EVP R&D Employee Stock Option (Right to Buy) 0 Dec 28, 2021 Direct

Insider Reports Filed by Bob D. Brown

Symbol Company Period Transactions Value $ Form Type Date Filed Role
DRNA Dicerna Pharmaceuticals Inc Dec 28, 2021 10 -$90.5K 4 Dec 29, 2021 Chief Scientific Ofr., EVP R&D
DRNA Dicerna Pharmaceuticals Inc Dec 15, 2021 3 -$63.7K 4 Dec 17, 2021 Chief Scientific Ofr., EVP R&D
DRNA Dicerna Pharmaceuticals Inc Nov 18, 2021 3 -$861K 4 Nov 22, 2021 Chief Scientific Ofr., EVP R&D
DRNA Dicerna Pharmaceuticals Inc Sep 17, 2021 1 -$448K 4 Sep 21, 2021 Chief Scientific Ofr., EVP R&D
DRNA Dicerna Pharmaceuticals Inc Aug 2, 2021 3 -$282K 4 Aug 3, 2021 Chief Scientific Ofr., EVP R&D
DRNA Dicerna Pharmaceuticals Inc Jul 1, 2021 4 -$282K 4 Jul 6, 2021 Chief Scientific Ofr., EVP R&D
DRNA Dicerna Pharmaceuticals Inc Jun 11, 2021 3 -$249K 4 Jun 15, 2021 Chief Scientific Ofr., EVP R&D
DRNA Dicerna Pharmaceuticals Inc Jun 7, 2021 3 -$239K 4 Jun 8, 2021 Chief Scientific Ofr., EVP R&D
DRNA Dicerna Pharmaceuticals Inc Jun 1, 2021 4 -$229K 4 Jun 3, 2021 Chief Scientific Ofr., EVP R&D